Name: | Glycopyrrolate |
---|---|
PubChem Compound ID: | 11693 |
Description: | A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics. |
Molecular formula: | C19H28BrNO3 |
Molecular weight: | 398.335 g/mol |
Synonyms: |
596-51-0; AHR 504; Pyrrolidinium, 1,1-dimethyl-3-hydroxy-, bromide, alpha-cyclopentylmandelate; Glycopyrrolate bromide; Gastrodyn; Glycopyrronii bromidum; Ritropirronium bromide [INN]; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate; Bromure de glycopyrronium [INN-French]; 53808-86-9.
show more » |
Name: | Glycopyrrolate |
---|---|
Name (isomeric): | DB00986 |
Drug Type: | small molecule |
Description: | A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics. |
Synonyms: |
Glycopyrronium bromide
|
Brand: | Robinul, Robinal, Asecryl, Robanul, Tarodyl, Tarodyn, Nodapton, Gastrodyn |
Category: | Muscarinic Antagonists, Adjuvants, Anesthesia, Anti-cholinergic Agents |
CAS number: | 596-51-0 |
Indication: | For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation. |
---|---|
Pharmacology: |
Glycopyrrolate decreases acid secretion in the stomach. Hence it can be used for treating ulcers in the stomach and small intestine, in combination with other medications. In anesthesia, glycopyrrolate injection serves as a preoperative antimuscarinic operation that reduces salivary, tracheobronchial, and pharyngeal secretions, as well as decreases...
show more » |
Mechanism of Action: |
Glycopyrrolate binds competitively to the muscarinic acetylcholine receptor. Like other anticholinergic (antimuscarinic) agents, it inhibits the action of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic rece...
show more » |
Absorption: | Rapidly absorbed (1-2 minutes) after intravenous injection |
Half Life: | 0.6-1.2 hours |
Toxicity: | Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. The medication also induces drowsiness or blurred vision. LD50=709 mg/kg (rat, oral). |
Affected organisms: | Humans and other mammals |
Food interaction: |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Drug interaction: |
|